Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (221-230 of 357) with videos related to

Pageof 36
Sort By:
Journal of Crohn'S & Colitis|August 30, 2024
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III TrialsRemo Panaccione, Christopher Ma, Vipul Jairath, et al.
Advances in Therapy|August 10, 2024
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect ComparisonsWalter Reinisch, Gil Y Melmed, Hiroshi Nakase, et al.
Crohn'S & Colitis 360|April 24, 2026
Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysisRuben J Colman, Sudheer K Vuyyuru, Virginia Solitano, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel diseaseChristopher Ma, Jeffrey K Lee, Anish R Mitra, et al.
Inflammatory Bowel Diseases|June 30, 2025
Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert OpinionCindy C Y Law, Rachel Sheskier, Natalia Viera-Feliciano, et al.
Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Journal of Crohn'S & Colitis|July 20, 2024
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY TrialChristopher Ma, Brian G Feagan, Zhongya Wang, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisTanmay Sharma, Christopher Ma, Rocio Sedano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysisDavid J Katibian, Virginia Solitano, D Brent Polk, et al.
Pageof 36

Showing results (221-230 of 357) with videos related to

Sort By:
Pageof 36
Journal of Crohn'S & Colitis|August 30, 2024
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III TrialsRemo Panaccione, Christopher Ma, Vipul Jairath, et al.
Advances in Therapy|August 10, 2024
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect ComparisonsWalter Reinisch, Gil Y Melmed, Hiroshi Nakase, et al.
Crohn'S & Colitis 360|April 24, 2026
Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysisRuben J Colman, Sudheer K Vuyyuru, Virginia Solitano, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel diseaseChristopher Ma, Jeffrey K Lee, Anish R Mitra, et al.
Inflammatory Bowel Diseases|June 30, 2025
Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert OpinionCindy C Y Law, Rachel Sheskier, Natalia Viera-Feliciano, et al.
Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Journal of Crohn'S & Colitis|July 20, 2024
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY TrialChristopher Ma, Brian G Feagan, Zhongya Wang, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisTanmay Sharma, Christopher Ma, Rocio Sedano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysisDavid J Katibian, Virginia Solitano, D Brent Polk, et al.
Pageof 36